Wird geladen...
Treatment compliance with first line disease-modifying therapies in patients with multiple sclerosis. COMPLIANCE Study
Introduction: Non-adherence to disease-modifying therapies (DMTs) in multiple sclerosis may be associated with reduced efficacy. We assessed compliance, the reasons for non-compliance, treatment satisfaction, and quality of life (QoL) of patients treated with first-line therapies. Methods: A cross-s...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier España
2015-05-01
|
| Schriftenreihe: | Neurología (English Edition) |
| Online Zugang: | http://www.sciencedirect.com/science/article/pii/S2173580815000346 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|